Integrative Medicine
RSSArticles
-
Full June 1, 2003 Issue in PDF
-
Full May 29, 2003 Issue in PDF
-
Clinical Briefs
Influenza Vaccination and Reduction in Hospitalizations; Screening Men for Prostate and Colorectal Cancer; Weight Loss in CHF and Treatment with ACE-I -
Pharmacology Update: Aprepitant Capsules (Emend — Merck & Co)
The FDA has approved aprepitant for preventing both acute and delayed nausea and vomiting associated with chemotherapy. -
The Urine Color Test with Isoniazid Treatment of Latent Tuberculosis Infection
Noncompliance with treatment for latent tuberculosis can be monitored with the aid of a special urine test that checks for metabolites of isoniazid. -
What Are the Chances That a Mole Will Turn to the Dark Side?
Although the phenomenon of cutaneous melanoma (CM) arising from melanocytic nevi (MN) is known, the transformation rate of MN into CM is not. Tsao and associates set out to calculate the rate, using published data and making some assumptions to ease the calculation. -
Obesity: Death, Dollars, and the Prospects for Treatment
The management of the obesity epidemic is complex, but there are some interventions that can be helpful. -
Silent Strokes Predispose to Dementia
This study concludes that there may be a direct association between ischemia and the development of Alzheimers pathology (plaques and neurofibrillary tangles), or alternatively, ischemia may unmask otherwise mild cases of AD. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Counterfeit Procrit Uncovered by FDA Surveillance
Counterfeit Procrit Uncovered by FDA Surveillance; Pharmaceutical Marketing Campaigns in Full Swing; Ambulatory Antibiotic Reduction: Take the Good with the Bad; Nefazodone Under Attack Once Again; Lindane Receives Black Box Warning; Aspirin Could Help Reduce Colorectal Adenomas